Clinical trial
IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity
NCT00465738 · Merz Pharmaceuticals GmbH, Industry · Completed
Key facts
| NCT number | NCT00465738 |
|---|---|
| Title | IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity |
| Official title | Prospective, Randomized, Observer-blind, Parallel-group, Multi-center Trial to Assess Efficacy and Safety of Two Different Dilutions of incobotulinumtoxinA (Xeomin) in Patients With Upper Limb Spasticity |
| Acronym | NT-Spin |
| Lead sponsor | Merz Pharmaceuticals GmbH, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Upper Limb Spasticity |
| Intervention type | Drug |
| Interventions | incobotulinumtoxinA (Xeomin, also known as "NT 201" or "Botulinum toxin type A (150 kD), free from complexing proteins") |
| Enrollment | 216 |
| Start date | Feb 1, 2007 |
| Primary completion | Jan 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Apr 25, 2007 |
| Last update posted | Dec 31, 2010 |
| Countries | Austria, France, Germany, Italy, Portugal, Spain, Switzerland, United Kingdom |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: